Looking at the studies discussed in this section, we can conclude that CD93 plays a key role in promoting the neovascularization of choriocapillaris in patients with AMD and that this effect can be blocked by using antibodies that hamper the CD93/MMRN2 interaction. The gene discussed is MMRN2; the disease is age-related macular degeneration.